Data for: Characteristics of Trials and Regulatory Pathways Leading to US Approval of Innovative Vs. Non-Innovative Oncology Drugs
Published: 26 April 2021| Version 1 | DOI: 10.17632/4g7gyk7gwp.1
Contributor:
Kerstin Noëlle VokingerDescription
Research Data
Files
Categories
Health Policy